NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 385.21% | 12.47% | 119.89% | -104.97% | 35.33% |
| Total Depreciation and Amortization | 16.26% | 10.33% | 10.67% | 9.03% | 7.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,449.48% | -0.60% | -145.64% | 299.67% | -143.39% |
| Change in Net Operating Assets | -61.05% | -288.50% | 67.21% | 131.38% | 953.24% |
| Cash from Operations | 30.59% | -0.20% | 14.68% | -8.48% | 17.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 11.11% | -- | 11.76% | -- |
| Cash from Investing | -248.57% | 11.11% | -- | 11.76% | 369.23% |
| Total Debt Issued | 28.22% | 7,995.00% | -78.56% | 2.93% | -73.68% |
| Total Debt Repaid | -- | -194.67% | -- | -- | -- |
| Issuance of Common Stock | -- | 310,700.00% | -79.06% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 92.71% | 222.72% | -21.42% | -- |
| Cash from Financing | -33.97% | 486.41% | -68.51% | -3.38% | -27.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,675.00% | 99.98% | -101.22% | -93.78% | -98.73% |